KL2 Scholar
Groups
June 29, 2021June is National Alzheimer's and Brain Awareness month. Scientists supported by the CTSA Program are contributing important research to help patients with neurodegenerative diseases. Click on the boxes below to learn more about what these researchers are studying and how the CTSA Program is impacting the field of neuroscience.
-Medical University Of South CarolinaThe CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
-Duke UniversityThe CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
-Rockefeller UniversityThe CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
-Rutgers Biomedical/Health SciencesThe CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
-University Of Wisconsin-MadisonThe CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
-University Of Pittsburgh At PittsburghThe CTSA Visiting Scholar program consists of giving the virtual CTSA Grand Rounds lecture, which is open to the entire CTSA Consortium, and virtual meetings between KL2 Scholars and faculty at the host institution and their KL2 peers. There are two main goals of this program. The first is to offer the opportunity to serve as a visiting professor and help make connections with faculty that will
-Harvard Medical SchoolKL2 awardees from clinical and translational science centers (CTSA) present virtual lectures as part of CTSA Visiting Scholar Program. Kelly Mahaney, MD, Stanford University, will present her research on intraventricular hemorrhage (IVH) clearance from cerebrospinal fluid (CSF) following severe hemorrhage in preterm neonates and the correlations with severe ventricular enlargement and clinical
November 23, 2021“Without a doubt, the support from the Georgia CTSA changed the trajectory of my career. It connected me to mentors, protected time and matched me with clinical research which is so important to me,” says Colleen S. Kraft, MD, MSc. Known as one of Emory’s leading infectious disease experts, Colleen S. Kraft, MD, MSc, is no stranger to today’s media outlets and the medical community for her role as
UC Davis CTSC KL2 Scholar, Temitayo Oyegbile-Chidi, Presents at Department of Neurology Grand Rounds
November 16, 2021Temitayo Oyegbile-Chidi, an associate professor in the Department of Neurology at UC Davis Health, provided a grand rounds presentation titled “Sleep & Wellness: The Effects of Sleep Disturbance on the Brain” on November 9, 2021. Dr. Oyegbile-Chidi discussed the neurobehavioral benefits of adequate sleep, some of the adverse effects of sleep restriction on the body and brain, and basic sleep
November 13, 2021Former KL2 scholars and current Georgia CTSA Research Education Program members, Dr. Igho Ofotokun and Dr. Rachel Patzer, along with Georgia CTSA Clinical Research Centers Co-Director, Dr. Priscilla Pemu, received a nearly $20M NIH grant as principal investigators of the Atlanta hub for RECOVER, a nationwide effort to study Long COVID effects. Georgia CTSA Community Engagement Director, Dr. Tabia
-University Of PennsylvaniaKL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Shirley Cohen-Mekelburg, MD, MS from the University of Michigan at Ann Arbor hosted by the University of Pennsylvania will present her research on Improving Care Coordination for Patients with Complex Specialty Care Needs: Inflammatory Bowel Disease as a Case
October 06, 2021Moises Huaman, MD, associate professor in the Department of Internal Medicine, Division of Infectious Diseases, University of Cincinnati and 2020 KL2 Program Graduate, will be one of three researchers for a virtual panel discussion “A Conversation with Latinx Researchers,” from 2:00-3:00p.m. on Thursday, October 14, 2021. Register for “A Conversation with Latinx Researchers”. The webinar will be
October 05, 2021Guizhi “Julian” Zhu, Ph.D., a Virginia Commonwealth University Wright Center KL2 Scholar alum and assistant professor in the VCU School of Pharmacy Department of Pharmaceutics, was awarded a five-year grant totaling $1.9 million to study a molecule with implications for the treatment of cancer, genetic diseases and more. The award, which started on Sept. 18, will fund Zhu and his team’s work on
September 29, 2021We sat down (virtually!) with Dr. Nhu Tran, a recipient of the SC CTSI Mentored Career Development in Clinical and Translational Science award. We hear about her new K23 grant from the National Institute of Nursing Research, within the National Institutes of Health, and what she hopes to learn. Congratulations to Dr. Tran on this great accomplishment! 1. In layperson’s terms, tell us a little
September 16, 2021Three Virginia Commonwealth University researchers were awarded funding that will support the expansion of their health research and translation of that research into improved care for patients. Wendy Bottinor, M.D., and Mathula Thangarajh, M.D., Ph.D., both from the VCU School of Medicine, and Jiong Li, Ph.D., from the VCU School of Pharmacy, are VCU’s 2021 KL2 scholars. The KL2 Mentored Career
September 02, 2021We sat down (virtually!) with Dr. Frank Attenello, a recipient of the SC CTSI Mentored Career Development in Clinical and Translational Science award. We hear about his new K08 grant from the National Institute of Neurological Disorders and Stroke within the National Institutes of Health, and what he hopes to learn. Congratulations to Dr. Attenello on this great accomplishment! 1. In layperson’s
August 24, 2021More than a decade ago, the VCU Wright Center inaugurated its first class of KL2 Scholars, a cohort of talented junior faculty members looking to advance the world’s knowledge of health through clinical and translational research. Since then, 14 researchers have enjoyed the mentorship, protected research time and general support of their research careers that KL2 Program affords them. Funded by
August 17, 2021Poor sleep impacts the risk of long-term cognitive decline in Hispanic/Latino middle-aged and older adults differently than it does in non-Hispanic adults, according to research led by University of Miami Miller School of Medicine neurology faculty and the largest long-term study of U.S. Hispanic/Latinos to date.
August 05, 2021We sat down (virtually!) with Dr. Roy Poblete, a recipient of the SC CTSI Mentored Career Development in Clinical and Translational Science and recipient of multiple SC CTSI funding awards. We hear from him about his new role as junior editor with the Journal of Clinical and Translational Science (JCTS), the official journal of the Association for Clinical and Translational Science, and the
July 30, 2021Former KL2 Scholar Dr. Javier López is an associate professor at the University of California Davis and the medical director of the university’s Cardiac and Vascular Rehabilitation Program. He researches biological processes that put patients who had a heart attack and received treatments for it at risk of having another. He also works in a student-run clinic to provide free care to patients
June 01, 2021Heather Siefkes, assistant professor in the UC Davis Department of Pediatrics, has received the 2021 Eli Gold Prize. Siefkes works in the Pediatric and Cardiac Intensive Care Unit at UC Davis Children’s Hospital and serves as medical director of Project ADAM Sacramento, which helps schools prepare for a sudden cardiac emergency through AED and CPR training. The prize was named for Eli Gold, former
May 28, 2021May is National Cancer Research Month, and Clinical and Translational Science Award (CTSA) Program hubs are on the forefront of cancer research. From genetic counseling to mining electronic health records, the CTSA Program is approaching cancer research from multiple directions, with the goal of getting treatments to patients more quickly. Click through the map below to see the contributions hubs
Black Voices in Research: University of Florida CTSI Provides a Platform for Underrepresented Voices
May 14, 2021The University of Florida CTSI is examining long-standing and unspoken issues of racial injustice, equality and diversity within the working environment of the clinical research professional workforce. Dressed in black, Tiffany Danielle Chisholm Pineda stood on a stage and spoke about her experience as a Black research professional working to eliminate personal biases in scientists. “Most of the
May 10, 2021Dr. Vanita R. Aroda, current Director of the Diabetes Clinical Research Program at Brigham and Women's Hospital and former GHUCCTS KL2 scholar, is featured in the piece "Vanita Aroda: the accidental role model… by no accident" published by The Lancet. Article abstract: Clinical academia is still male-dominated in many fields, including diabetes and endocrinology. This makes the achievements of
-Johns Hopkins UniversityJo Ellen Wilson, MD, MPH, visiting KL2 scholar from Vanderbilt University, will be hosted by the Johns Hopkins Clinical Research Scholars (KL2) Program. Dr. Wilson will be presenting her work on "Disentangling Acute Brain Dysfunction in the ICU: Current Progress and Future Direction".
-University Of California San DiegoKL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Sarah E. Lutz, PhD from the University of Chicago, hosted by the University of California San Diego will present her research on Blood-Brain Barrier Caveolin-1 Promotes Leukocyte Vascular Extravasation in CNS Autoimmunity.
-
-Johns Hopkins University
Lavanya Vasudevan, PhD, MPH, visiting KL2 scholar from Duke University, will be hosted by the Johns Hopkins International Vaccine Access Center in the lead up to World Immunization Week. Dr. Vasudevan will be presenting her work on "Addressing Global Vaccine Hesitancy - Challenges & Opportunities".
-Wake Forest University Health SciencesKL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Kirsten M. Wright, ND, MCR, MS from Oregon Health and Science University hosted by Wake Forest School of Medicine will present her research on "Using a Home-Based Monitoring Platform to Explore Real-World Routines and Nutrition Behavior in Older Adults at Risk
-NCATSKL2 awardees from Clinical and Translational Science Centers (CTSA) present virtual lectures as part of the CTSA Visiting Scholar Program. Mathew Cherian MD, from Ohio State University, hosted by the National Center for Advancing Translational Sciences will present his research on "Tolerable Strategies to Overcome Treatment Resistance in Breast Cancer" Resistance to first-line endocrine and cyclin